Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Treatment of autoimmune hemolytic anemias
Alberto Zanella, Wilma Barcellini
Haematologica (2014) Vol. 99, Iss. 10, pp. 1547-1554
Open Access | Times Cited: 243

Showing 1-25 of 243 citing articles:

Guidelines on the Use of Therapeutic Apheresis in Clinical Practice–Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Seventh Special Issue
Joseph E. Schwartz, Anand Padmanabhan, Nicole A. Aqui, et al.
Journal of Clinical Apheresis (2016) Vol. 31, Iss. 3, pp. 149-338
Closed Access | Times Cited: 668
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice—Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Sixth Special Issue
Joseph E. Schwartz, Jeffrey L. Winters, Anand Padmanabhan, et al.
Journal of Clinical Apheresis (2013) Vol. 28, Iss. 3, pp. 145-284
Closed Access | Times Cited: 581
How I treat autoimmune hemolytic anemia
Ronald S. Go, Jeffrey L. Winters, Neil E. Kay
Blood (2017) Vol. 129, Iss. 22, pp. 2971-2979
Open Access | Times Cited: 174
Sutimlimab in Cold Agglutinin Disease
Alexander Röth, Wilma Barcellini, Shirley D’Sa, et al.
New England Journal of Medicine (2021) Vol. 384, Iss. 14, pp. 1323-1334
Open Access | Times Cited: 156
Sutimlimab in patients with cold agglutinin disease: results of the randomized placebo-controlled phase 3 CADENZA trial
Alexander Röth, Sigbjørn Berentsen, Wilma Barcellini, et al.
Blood (2022) Vol. 140, Iss. 9, pp. 980-991
Open Access | Times Cited: 73
Warm antibody autoimmune hemolytic anemia
Theodosia A. Kalfa
Hematology (2016) Vol. 2016, Iss. 1, pp. 690-697
Open Access | Times Cited: 116
Inhibition of complement C1s improves severe hemolytic anemia in cold agglutinin disease: a first-in-human trial
Ulrich Jäger, Shirley D’Sa, Christian Schörgenhofer, et al.
Blood (2018) Vol. 133, Iss. 9, pp. 893-901
Open Access | Times Cited: 98
Cold Agglutinin-Mediated Autoimmune Hemolytic Anemia
Sigbjørn Berentsen, Ulla Randen, Geir E. Tjønnfjord
Hematology/Oncology Clinics of North America (2015) Vol. 29, Iss. 3, pp. 455-471
Closed Access | Times Cited: 97
Red Blood Cell Destruction in Autoimmune Hemolytic Anemia: Role of Complement and Potential New Targets for Therapy
Sigbjørn Berentsen, Tatjana Sundic
BioMed Research International (2015) Vol. 2015, pp. 1-11
Open Access | Times Cited: 92
The Epidemiology and Clinical Manifestations of Autoimmunity in Selective IgA Deficiency
David D. Odineal, M. Eric Gershwin
Clinical Reviews in Allergy & Immunology (2019) Vol. 58, Iss. 1, pp. 107-133
Open Access | Times Cited: 91
New Insights in Autoimmune Hemolytic Anemia: From Pathogenesis to Therapy
Wilma Barcellini, Anna Zaninoni, Juri Alessandro Giannotta, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 12, pp. 3859-3859
Open Access | Times Cited: 85
Prognostic significance of hemoglobin level and autoimmune hemolytic anemia in SARS-CoV-2 infection
Abdulrahman Algassim, Assem Elghazaly, Abeer S. Alnahdi, et al.
Annals of Hematology (2020) Vol. 100, Iss. 1, pp. 37-43
Open Access | Times Cited: 77
Sovleplenib in patients with primary or secondary warm autoimmune haemolytic anaemia: results from phase 2 of a randomised, double-blind, placebo-controlled, phase 2/3 study
Xin Zhao, Jing Sun, Zhihua Zhang, et al.
The Lancet Haematology (2025)
Closed Access | Times Cited: 1
A hyper-acute immune hemolytic anemia induced by contrast medium was successfully treated with eculizumab: a case report
Sabine Hermann, Karina Althaus, Migdat Mustafi, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access | Times Cited: 1
Short course of bortezomib in anemic patients with relapsed cold agglutinin disease: a phase 2 prospective GIMEMA study
Giuseppe Rossi, Doriana Gramegna, Francesca Paoloni, et al.
Blood (2018) Vol. 132, Iss. 5, pp. 547-550
Open Access | Times Cited: 77
Treatment Options for Primary Autoimmune Hemolytic Anemia: A Short Comprehensive Review
Abdulgabar Salama
Transfusion Medicine and Hemotherapy (2015) Vol. 42, Iss. 5, pp. 294-301
Open Access | Times Cited: 76
Autoimmune Hemolytic Anemia
Howard A. Liebman, Ilene C. Weitz
Medical Clinics of North America (2016) Vol. 101, Iss. 2, pp. 351-359
Closed Access | Times Cited: 75
BACTERIAL INFECTIONS FOLLOWING SPLENECTOMY FOR MALIGNANT AND NONMALIGNANT HEMATOLOGIC DISEASES
Giuseppe Leone, Eligio Pizzigallo
Mediterranean Journal of Hematology and Infectious Diseases (2015) Vol. 7, pp. e2015057-e2015057
Open Access | Times Cited: 74
The role of rituximab in adults with warm antibody autoimmune hemolytic anemia
Daan Dierickx, Alain Kentos, André Delannoy
Blood (2015) Vol. 125, Iss. 21, pp. 3223-3229
Open Access | Times Cited: 73
Immunotherapy-associated autoimmune hemolytic anemia
Uqba Khan, Farman Ali, Muhammad Khurram, et al.
Journal for ImmunoTherapy of Cancer (2017) Vol. 5, Iss. 1
Open Access | Times Cited: 70
Evans Syndrome in Children: Long-Term Outcome in a Prospective French National Observational Cohort
Nathalie Aladjidi, Helder Fernandes, Thierry Leblanc, et al.
Frontiers in Pediatrics (2015) Vol. 3
Open Access | Times Cited: 65
Autoimmune Hemolytic Anemia in the Pediatric Setting
Aikaterini Voulgaridou, Theodosia A. Kalfa
Journal of Clinical Medicine (2021) Vol. 10, Iss. 2, pp. 216-216
Open Access | Times Cited: 48
A Practical Perspective of the Hematologic Manifestations of Systemic Lupus Erythematosus
Juan Camilo Santacruz, Marta Juliana Mantilla, I. Rueda, et al.
Cureus (2022)
Open Access | Times Cited: 31
Venous thromboembolism related to warm autoimmune hemolytic anemia: A case–control study
M. Lecouffe-Desprets, A. Néel, J. Graveleau, et al.
Autoimmunity Reviews (2015) Vol. 14, Iss. 11, pp. 1023-1028
Closed Access | Times Cited: 52
Fostamatinib for the treatment of warm antibody autoimmune hemolytic anemia: Phase 2, multicenter, open‐label study
David J. Kuter, Kerry A. Rogers, Michael Boxer, et al.
American Journal of Hematology (2022) Vol. 97, Iss. 6, pp. 691-699
Open Access | Times Cited: 26
Page 1 - Next Page

Scroll to top